Then, the results of chromatin immunoprecipitation (ChIP) assays confirmed that STAT1 physically bound to the promoter region of ZFPM2-AS1 in HCC cells and we observed marked enrichment of site#2 by STAT1 antibody when compared with the negative control (Fig. 2H). The gene discussed is STAT1; the disease is hepatocellular carcinoma.